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Abstract 
A previous study showed that a single nucleotide polymorphism (SNP), –1438G/A (rs6311), 
found in the transcriptional control region of the gene that encodes the serotonin-receptor 2A 
(HTR2A) was associated with obsessive-compulsive disorder (OCD) in a sample of children and 
adolescents. In this study, we reanalyzed the association of this SNP with OCD in an enlarged 
population of 136 cases (55 previous + 81 new cases) and compared them to 106 newly 
recruited, healthy, age-matched controls. We also investigated whether this SNP or its copy 
number variations (CNV) was associated with OCD severity and age of onset. The CNV was 
analyzed in a DNA region located near rs6311. The results confirmed the association between the 
A-allele and early-onset OCD in children and adolescents, with an Odds Ratio (OR) of 1.69 
(95% CI: [1.17, 2.46]; p=0.005). Strikingly, we found that carriers of one copy (deletion) of the 
CNV were associated with a very early-onset OCD (2.5 years earlier than the typical onset), and 
they had increased Y-BOCS scores (8.7 points higher compared to “normal” CNV and 
duplications); which is related to increased severity of OCD symptoms (p=0.031; p=0.004, 
respectively). Compared to the normal CNV and duplications, the association between the 
deletion and OCD showed an OR of 7.56 (95% CI: [1.32, 142.84]; p=0.020). These results 
pointed to the functional importance of this promoter region of HTR2A; it influenced the 
occurrence, the onset, and the severity of OCD.  
 
 
Keywords: obsessive-compulsive disorder; HTR2A polymorphism; child and adolescent 
psychiatry; copy number variation 
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Introduction 
Obsessive-compulsive disorder (OCD) is a heterogeneous psychiatric disorder characterized by 
clinically significant, recurrent, intrusive, and disturbing thoughts (obsessions), accompanied by 
repetitive, stereotypic behaviors, usually associated with anxiety or dread (compulsions) (1). 
According to the National Comorbidity Survey Replication, the median age of OCD onset is 19 
years. However, symptoms of OCD often begin during childhood or adolescence; in fact, 21% of 
all cases start experiencing symptoms by 10 years old (2, 3). Kessler and colleagues found that, 
among anxiety disorders, OCD had the highest percentage (50%) of severe cases (3); 
furthermore, early-onset OCD often develops a chronic course and has a poor long-term 
outcome. Formal genetic studies showed that OCD had a high familial component, particularly 
early-onset OCD (4); however, the definition of early-onset OCD differs among studies. 
Dysfunction of the serotonin (5-HT) system has been implicated in OCD and is thought to 
contribute to behavioral traits, like perfectionism, obsessiveness, anxiety, and depression (5-7). 
Additionally, there is evidence that 5-HT is involved in eating disorders (8, 9). Obsessive, 
restrictive behaviors and perfection-seeking personalities are often found in patients with 
anorexia nervosa (9, 10). Selective serotonin re-uptake inhibitors (SSRI; e.g., fluoxetine) that 
block the serotonin transporter represent the most effective pharmacological treatment of OCD, 
early-onset OCD, and anxiety disorders. A meta-analysis (11) was conducted on 12 randomized 
double-blind placebo controlled studies that tested SSRI and clomipramine treatments for OCD 
and included 1044 affected children and adolescents. The effect size was a pooled standardized 
mean difference of 0.46 for SSRIs and clomipramine compared to placebo (11). In the pediatric 
OCD Treatment Study (POTS), fluoxetine was found to be effective, and it ameliorated the 
effects of behavioral therapy (12). Therefore, most genetic association studies in OCD have 
investigated genes related to serotonergic signaling. Association studies in early-onset OCD are 
rare, but there is extensive evidence that the heritability of early-onset OCD is higher than the 
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heritability of later onset OCD (onset after 18 years old) (4). Our group previously conducted an 
association study to determine whether early-onset OCD was associated with the single 
nucleotide polymorphism (SNP), -1438A/G (rs6311), in the serotonin receptor 2A (HTR2A) 
promoter (13). We applied a case-control design in a pediatric sample and detected a significant 
association of the A-allele with OCD (13). Our results were in accordance with the results from a 
study conducted by Enoch and colleagues in adult patients with OCD (10, 14). Those authors 
also described a correlation between the -1438A-allele and early-onset OCD that was determined 
retrospectively (10, 14). In those studies, the effect size was more pronounced in female patients 
(14). However, several other case-control association studies on adult OCD subjects (15-17) 
reported no association with SNP rs6311. Similarly, several association studies for the 
synonymous T102C (rs6313) variant, which was reported to be in complete linkage 
disequilibrium with rs6311 in different populations (18-21), reported conflicting results in adult 
OCD subjects (16, 17, 19, 22-24). Dickel et al. (2007) (25) conducted transmission-
disequilibrium tests and failed to find an association between the rs6311 polymorphism and 
early-onset OCD (25); however, they reported a significant association between OCD and a 
comorbid tic disorder. Therefore, further studies are required to resolve these conflicting results. 
In parallel, recent investigations have implicated de novo and/or rare copy number variations 
(CNVs) as potentially pathogenic factors in attention-deficit/hyperactivity disorder (26-28), 
autism (29-31), and schizophrenia (30, 32, 33). The duplication or deletion process of CNVs can 
disrupt a variable number of genes, which can result in alternate gene products or changes in 
gene dosage. Moreover, the disruption of regulatory regions in the genome can lead to altered 
gene expression, and this may contribute to disease predisposition. Given the highly heritable 
and variable nature of OCD, we hypothesized that individual, rare CNVs near the SNP rs6311 
might contribute to OCD risk and severity.  
In the present study, we extended the number of patients included in our previous study (13) and 
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also included new independent controls. We aimed to confirm our previous results of the 
association between the rs6311 polymorphism and early-onset OCD. In addition, we aimed to 
investigate the association between early-onset OCD and CNVs located near SNP rs6311. 
 
Results 
Demographic data 
The study population included slightly more males than females in both the OCD and the healthy 
control groups (p=0.51). The healthy controls were significantly younger than the OCD cases 
(p<0.0001); however, the average age of the controls was not significantly different from the 
average age of the subjects at OCD onset (p=0.21). 
HTR2A -1438 A/G polymorphism and CNV associations with age of onset and severity of OCD 
The HTR2A genotype was not significantly associated with age of onset or severity of OCD in 
the case population (Table 1A). In addition, there was no significant difference between 
“normal” and “high” CNV with respect to age of onset or severity (t-test p=0.47 and p=0.30, 
respectively). Because we hypothesized that the deletion (“low” CNV) would affect the 
phenotype by impairing the function of the promoter activity, we pooled the normal and high 
data into a joint normal/high CNV group for comparisons to the low CNV group (Table 1B). 
This analysis method revealed a significant association between “low” CNV and the age of onset 
(p=0.031); the estimated average age of onset was 2.5 years earlier than that of the normal/high 
group (95% confidence interval (CI): [0.2 years, 4.8 years]). Similarly, we observed a significant 
association between “low” CNV and the OCD severity measured with Y-BOCS scores 
(p=0.004); the estimated average severity score was 8.7 points higher than that of the 
normal/high group (95% CI: [2.9 points, 14.5 points]). 
Case-control analysis of the HTR2A -1438 A/G polymorphism and CNV 
The association between SNP rs6311 and OCD was first analyzed in only the 81 newly recruited 
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patients with OCD (those not included in the previous study (13). There was a significant 
difference between the genotype distributions of controls and these OCD cases (p=0.030). Note 
that the previous study, with a different control group and a smaller OCD group, also reported a 
significant association between genotype and OCD (p=0.046). When all 135 available cases with 
SNP information were included, the association was highly significant (p=0.007). We also found 
that the OCD cases showed a higher frequency of the AA genotype (19.3%) compared to the 
healthy controls (16%) (Table 2). The estimated OR for the A allele was 1.69 (95% CI: [1.17, 
2.46]; p=0.005), adjusted for CNV. Assuming an additive effect of the A allele, this indicated that 
the risk of OCD was increased by 69% in patients with the heterozygous GA genotype and by 
286% for the homozygous AA genotype. 
The association (adjusted for SNP) between the HTR2A CNV (“low“ vs. “normal/high“) and 
OCD was also significant (p=0.020). The SNP-adjusted OR estimated for a “low” CNV relative 
to a “normal/high” CNV was 7.56 (95% CI: [1.32, 142.84]). We did not find a significant gender 
effect in our case-control analysis (p=0.72). 
 
Discussion 
In this study, we confirmed the previously described association between the A-allele of SNP 
rs6311 and OCD, particularly in children and adolescents (10, 13, 14). We estimated that the OR 
per A-allele was 1.69 (95% CI: [1.17, 2.46]) for early-onset OCD, and we found no significant 
association between age of onset and OCD severity. This might be due to the fact that the OCD 
population in this study contained only patients with very early-onset of the disease (average age 
of onset was 11.1±3.2 years, range 3-17.4 years). Thus, we could not rule out an age dependent 
association for the-rs6311 A-allele. For example, age might be detected as a factor in an analysis 
of patients that experienced OCD onsets at all ages, from 3 to >18 years. That association could 
be a result of polymorphism influence on HTR2A gene expression through the promoter activity. 
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An extensive reporter gene assay suggested that the rs6311 SNP modulated HTR2A promoter 
activity (34); however, another study on the effect of the rs6311 SNP on promoter activity 
revealed no significant difference in expression of HTR2A mRNA (18).  
An important feature of HTR2A expression is its monoallelic expression. HTR2A is imprinted in 
human fibroblasts, which express only the maternal allele (35). Polymorphic imprinting in adult 
human brains was reported in a subset of heterozygotes, but the parental origin of the expressed 
allele was not analyzed (36). Analyses of DNA and mRNA related to the 102T/C polymorphism 
(rs6313) of the HTR2A gene revealed that 102C was expressed at lower levels than 102T in brain 
tissue (37). In contrast to this biallelic expression observed in the brain, monoallelic expression 
of HTR2A was common in peripheral lymphocytes (37). However, a familial study revealed that 
imprinting was not responsible for the monoallelic expression in peripheral lymphocytes (37). A 
recent report demonstrated that HTR2A mRNA expression in human fibroblast cell lines 
reflected a significant overall genotypic effect; subjects with the AA genotype at the –1438 locus 
(rs6311) had significantly higher levels of HTR2A mRNA compared to subjects with the AG 
genotype, but not compared to those with the GG genotype (38). Moreover, the –783A/G 
(rs6312) polymorphism significantly modified the effect of –1438A/G on HTR2A mRNA 
expression. When the -783 G-allele occurred in conjunction with the G-allele of the rs6311 
polymorphism, the HTR2A promoter activity was significantly reduced compared to other 
genotypes (38). A recent study reported an in silico selection of phenotypes that reflected 
different polymorphisms in the HTR2A gene (39). The SNP rs6311 was found to cause loss of 
the E2F1 transcription factor site and the gain of two other transcription factor sites (HAND1E47 
and SMAD; See Fig. 1). Another investigation of epigenetic factors affected by rs6311 revealed 
that a newly created E47 binding site (A-allele), a glucocorticoid receptor binding site at position 
-1420, and an Sp1 binding site at CpG methylation site +1224 caused alterations in methlylation 
rates at both -1420 and -1439 sites (40). Therefore, modifiers should be taken into account in 
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functional studies. 
One problem with genetic analyses is the inability to completely match a control group or de-
emphasize ethnic differences between patients and controls. In the present study, we included 
136 German patients with early-onset OCD, of which 107 patients were children from 
Würzburg, Germany. All patients and controls were of German origin. Furthermore, all 106 
healthy German children were also recruited at the Department of Child and Adolescent 
Psychiatry of the University of Würzburg; therefore, we assumed that we were able to de-
emphasize ethnic stratification.  
We also found that one copy (deletion) of a CNV located near the rs6311 was associated with 
very-early-onset OCD and an increased Y-BOCS score, which was related to enhanced symptom 
severity. Of note, the frequency of this deletion in our OCD group (n=8) was increased compared 
to that in the healthy controls (n=1). Characterizations of CNVs and their associated 
polymorphisms are important, because they may provide key links to understanding of the 
genetic basis of quantitative traits and the different susceptibilities to psychiatric diseases. An 
initial study that explored the effects of CNVs on gene expression in lymphoblastoid cell lines 
from human populations reported that changes in copy number explained nearly 20% of the 
detected gene expression variation (41). This was suggested to result from altered dosages of 
genes that mapped within CNVs; however, it may also potentially result from the impact of 
CNVs on neighboring genes (41, 42). Recent studies have shown that CNVs can influence the 
expression of genes both within the CNV and outside the CNV, in the vicinity of up to half a 
megabase (43). It was suggested that, for disorders like Williams-Beuren (WBS; MIM 194050), 
Prader-Willi (MIM 176270), Angelman (MIM 105830), and DiGeorge/velocardio-facial 
syndromes (DG/VCFS; MIM 188400), patients with duplications might have different clinical 
syndromes and milder phenotypic features than those with deletions. This might be explained by 
the fact that excess information tends to be less detrimental to the organism than a deficiency 
PNAS                              Research report-Biological Sciences Walitza et al. 2011 
 9
(44, 45). This effect might explain our observations of the effect that the “low” CNV had on the 
HTR2A promoter region; this effect might also influence promoter activity. A potential 
mechanism might be the loss of transcription factor sites within the CNV deletion (see Fig. 1). 
However, this theory requires further investigation. 
These findings may suggest additional applications for investigating the genomic effects 
associated with OCD in large-scale populations. 
 
Material and Methods 
Subjects 
The study sample comprised patients that had received in-patient treatment at the Department of 
Child and Adolescent Psychiatry of the Universities of Würzburg, Marburg, Aachen, and 
Freiburg. All patients and healthy controls were of German ethnicity. All participants and the 
parents of minors gave written informed consent. The ethics committees of all participating 
universities approved the study. 
Patients fulfilled the diagnostic criteria for current OCD according to the Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-IV) ((1) and the International 
Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) (46). 
To assess the criteria for OCD and comorbid psychiatric disorders, both patients and parents 
were interviewed separately with the semi-structured diagnostic interview of psychiatric 
disorders in children and adolescent (DIPS; children and parents version) (47). The DIPS is used 
to assess a wide range of psychiatric disorders in childhood and adolescence, including 
schizophrenia and allied disorders, autistic spectrum disorders, attention-deficit/hyperactivity 
disorder (ADHD), and conduct and oppositional-, anxiety-, affective-, eating- and tic-disorders, 
diagnosed according to the criteria of the ICD-10 (46). The DIPS further includes a general 
clinical screening component to assess substance use, abuse, and somatic diseases.  
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The children and adolescents were interviewed and evaluated with the Yale-Brown Obsessive 
Compulsive Scale (Y-BOCS) (48) to assess further characteristics and severity of OCD. A 
summary score above 16 points was determined to be the cut-off for clinical impairment caused 
by OCD symptomatology; a score of 38 points was the maximum for describing severity 
according to the Y-BOCS. Of note, the DSM-IV does not require children to fulfill the criterion 
of insight regarding the irrationality of the symptoms. This may result in low summary scores; 
therefore, it is possible that the Y-BOCS evaluations underestimated the true severity of 
symptomatology. For diagnostic assessments of present and lifetime Tourette´s Syndrome and 
tic-disorders, we used the adapted German version (49) of the Child and Adult Schedule for 
Tourette and Other Behavioral Syndromes (STOBS), according to Pauls et al. (50).  
All interviews were performed by senior clinicians of the university clinics for child and 
adolescent psychiatry. Subjects with comorbid disorders were only included in the study when 
the OCD symptoms were most prominent, based on two criteria: 1) OCD had to predate the 
onset of the comorbid disorders (except ADHD), and 2) two senior clinicians independently 
diagnosed the predominance of the OCD symptoms.  
Exclusion criteria for patients were: Lifetime history of psychotic disorders, Gilles-de-la-
Tourette’s syndrome and chronic tic-disorder, autistic spectrum disorder (e.g., infantile autism, 
atypical autism, Asperger´s syndrome), alcohol dependence, or mental retardation (IQ < 70). 
The patient sample consisted of 136 patients (children and adolescents, 77 males, 59 females) 
with a mean age at investigation of 13±2.9 years (range: 4.7 to 17.9 years). The mean age of 
onset was 11.1±3.2 years (range: 3 to 17.4 years). The patient sample was a superset that 
comprised 55 children with OCD from a previous study (13), plus 81 newly recruited children 
with OCD. Of the total 136 patients, 74 (54.4%) had no comorbid diagnosis, and 61 had a 
current diagnosis of comorbidity. The most frequent comorbidities were ADHD (n =15), anxiety 
disorders (n =10), depressive disorders (n =8), eating disorders (n =5), and conduct disorders (n 
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=4). The remaining cases had one of the following disorders: dyslexia, enuresis, or other 
behavioral and emotional disorders. Thirteen patients had a lifetime-diagnosis of tic-disorder 
according to STOBS.  
In a previous case-control study regarding the −1438G/A polymorphism in early-onset OCD 
(13), the control group consisted of students that were older than the patients. For this study, we 
recruited 106 healthy German children from the Department of Child and Adolescent Psychiatry 
of the University of Würzburg to use as new independent controls. The mean age of the controls 
was 11.6±2.6 years, and 38.7% of the controls were female. They were screened with the Child 
Behavior Checklist (CBCL) (51) and a validated German depression self-rating inventory (DIKJ) 
(52). All controls and their mothers were interviewed with the Schedule for Affective Disorders 
and Schizophrenia for school-aged children (Kiddie-Sads) (53). The intelligence level was 
assessed with the Culture Fair Test (CFT 1/20) (54, 55). Exclusion criteria for participation of 
controls were: any severe somatic or neurological disease; any psychiatric diagnosis according to 
the Kiddie-Sads; a DIKJ score that exceeded the threshold of 18 for clinically relevant 
depressive symptoms; any T-score above 63 on the internalizing, externalizing, or total score of 
the CBCL; or an IQ below 80. 
Genotyping for the HTR2A -1438 A/G polymorphism 
Genomic DNA was extracted from whole blood with the desalting Proteinase K methodology 
(56). Genotyping for the -1438 A/G polymorphism (rs6311) (location 47,471,478 on the 
GRCh37; 13q14 q21) was conducted with the TaqMan® SNP genotyping assay (Assay no. C-
8695278-10; Applied Biosystems Co., Germany) on the iCycler iQ Real-Time thermocycler 
(BioRad Laboratories Inc., Germany), according to manufacturer instructions. Genotypes were 
assessed according to the Allelic discrimination method with the iCycler IQ software (version 
3.1.7050; BioRad Laboratories, Germany). 
Copy number variation analysis 
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The CNV located 68 bp downstream of SNP rs6311 (location 47,471,310-47,471,410 on 
GRCh37; 13q14.2a; amplicon size 100 bp; Fig. 1) was analyzed with the TaqMan® Copy 
Number Assay (Assay no. Hs06366812_cn; Applied Biosystems Co., Germany) on the iCycler 
iQ Real-Time thermocycler (BioRad Laboratories Inc., Germany), according to manufacturer 
instructions. Each sample was adjusted to 20 ng genomic DNA per well. The TaqMan® Copy 
Number Reference assay for RNase P was used for normalization. Four replicates were run per 
sample. The CNV per sample were evaluated by the Cycles threshold (CT) values assigned with 
the CopyCaller® software (version 1.0; Applied Biosystems Co., Germany). A “normal“ CNV 
was defined as two copies; a “low” CNV was defined as ≤1 copy (deletion); and a “high” CNV 
was defined as  ≥3 copies (duplication). For each sample, an independent replication of the assay 
was conducted in order to eliminate false determinations of CNV. 
Statistical Analysis 
All statistical tests were two-sided with an alpha-level of 0.05. The results were unadjusted for 
multiple testing, because the analysis was exploratory and the number of tests was comparably 
small. All confidence intervals were 95% profile likelihood intervals (57).  
Gender and age distributions were compared with Fisher's exact test and the Student t-test, 
respectively. Differences in average OCD onset and severity (measured by the Y-BOCS score) 
were assessed with one- and two-way ANOVAs for separate and simultaneous comparisons, 
respectively. In the case-control analysis, discrepancies in SNP and CNV distributions were 
separately tested with Armitage's trend test and Fisher's exact test, respectively (58). Logistic 
regression for a simultaneous association analysis of SNP and CNV with OCD assumed an 
additive model for SNP and an unrestricted model for CNV. An additional interaction of SNP 
with gender was tested with the Student t-test. 
The computations were performed with the statistical computing software R (59), version 2.11.0. 
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Figure Legend 
Figure 1. Alignment of CNV and SNP rs6311 on the HTR2A promoter sequence and their 
effects on transcription factors. A) The alignment of HTR2A on chromosome 13. B) The HTR2A 
gene alignment with its promoter region (not to scale). C) The promoter region with the CNV 
and rs6311 alignment (not to scale); the indicated transcription factors may be affected according 
to PROMO version3 (http://algenn-lsi.ups.es). Red: G-allele; Green: A-allele; +: gain, and –: 
loss, of transcription factors (according to Pita et al. 2010). 

PNAS Biological Sciences Walitza et al. 2011 
 1
Table 1: Age at onset and severity of OCD, based on the SNP rs6311 genotype (A) and the 
CNV size (B)  
A) Genotype 
(rs6311) 
Age at onset (years) 
(mean±SD) 
N Missing Y-BOCS (score) 
(mean±SD) 
N Missing 
GG 11.0±3.3 38 1 23.9±8.4 34 5 
GA 10.9±3.3 65 5 21.7±7.0 66 4 
AA 11.7±2.6 25 1 21.0±8.4 26 0 
One-way ANOVA p=0.55   p=0.28   
Two-way ANOVA 
(adjusted for CNV) 
p=0.48   p=0.29   
Two-way ANOVA 
(adjusted for CNV-pooled) 
p=0.44   p=0.33   
One sample missing for the genotyping from technical reasons. 
B) CNV Age at onset 
(years) 
(mean±SD) 
Estimate 
(95% CI) 
(years)* 
N Missing Y-BOCS 
(score) 
(mean±SD)
Estimate 
(95% CI) 
(score)* 
N Missing 
Normal/High 11.2±3.0  120 7 21.7±7.6  119 8 
Low 8.8±4.8 -2.5 (-0.2; -
4.8) 
8 0 30.6±3.7 8.7 (2.9; 
14.5) 
7 1 
One-way 
ANOVA 
p=0.036    p=0.003    
Two-way 
ANOVA* 
p=0.031  p=0.004   
One sample missing for the CNV from technical reasons. 
*Estimates and confidence intervals (CIs) are adjusted for SNP 
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Table 2: Frequencies of SNP rs6311 genotypes and CNV sizes in subjects with OCD and 
healthy controls 
Genotype 
(rs6311) 
Controls 
N (frequency %) 
OCD 
N (frequency %) 
GG 54 (50.9) 39 (28.9) 
GA 35 (33.0) 70 (51.9) 
AA 17 (16.0) 26 (19.3) 
Fisher's exact test  p=0.002 
Armitage's test for trend  p=0.007 
Two-sided asymptotic (adjusted for CNV-pooled)  p=0.005 
CNV Controls 
N (frequency %) 
OCD 
N (frequency %) 
Normal/High 105 (99.1) 127 (94.1) 
Low 1 (0.9) 8 (5.9) 
Fisher's exact test  p=0.082 
Two-sided asymptotic (adjusted for SNP)  p=0.020 
One sample missing for the genotyping and one for CNV from technical reasons. 
 
